A new obesity drug that Eli Lilly is researching but hasn’t approved is turning up online, even though it’s not supposed to be available.
Here & Now‘s Peter O’Dowd speaks with Sarah Zhang, staff writer at the Atlantic.
This article was originally published on WBUR.org.
Copyright 2026 WBUR
